Securities Investigation – Actinium Pharmaceuticals
Are you concerned about your investment in Actinium Pharmaceuticals? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) is a clinical stage biopharmaceutical company developing innovative targeted therapies for patients with cancers lacking effective treatment options, according to its website.
According to SEC filings, Actinium Pharmaceuticals filed a Form D to raise capital from investors in 2012 in New York, NY. The total offering amount was $15,000,000.00.
Investments such as these are typically sold by brokerage firms in exchange for a large up front commission. High fees can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%.
The problem with private placement investments such as Actinium Pharmaceuticals is that they involve a high degree of risk. They are typically sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks or bonds. These investments may seem wise at first, until the dramatic drop in distributions.
The Risks of Private Placement Investments
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for unsuitably recommending high-risk private placements, like Actinium Pharmaceuticals, to investors.
Despite the risks of investing in private placements, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation.
If you have concerns regarding your investment in Actinium Pharmaceuticals and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://whitesecuritieslaw.com.
Tags: Actinium Pharmaceuticals complaints, Actinium Pharmaceuticals help, Actinium Pharmaceuticals high commissions, Actinium Pharmaceuticals information, Actinium Pharmaceuticals investigation, Actinium Pharmaceuticals investment, Actinium Pharmaceuticals investment losses, Actinium Pharmaceuticals investor relations, Actinium Pharmaceuticals investors, Actinium Pharmaceuticals losses, Actinium Pharmaceuticals ppm, Actinium Pharmaceuticals private placement, Actinium Pharmaceuticals prospectus, Actinium Pharmaceuticals real estate, Actinium Pharmaceuticals recovery options, Actinium Pharmaceuticals risk, Actinium Pharmaceuticals update Last modified: November 20, 2018